Enliven Therapeutics, Inc. (ELVN)

USD 16.18

(8.52%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 271.86 Million 83.29 Million 113.32 Million 131 Million 33.29 Million 7.7 Million
Total Current Assets 266.15 Million 77.75 Million 110.67 Million 130.58 Million 30.62 Million 7.7 Million
Cash And Short Term Investments 253.2 Million 75.53 Million 110.02 Million 130.36 Million 28.9 Million 7.38 Million
Cash and Cash Equivalents 100.19 Million 75.53 Million 110.02 Million 130.36 Million 4.93 Million 7.38 Million
Short Term Investments 153 Million - 41.96 Million 40.52 Million 23.97 Million -
Net Receivables - - - - - -
Inventory - - - - - -
Other Current Assets 12.94 Million 2.21 Million 646 Thousand 222 Thousand 1.71 Million 323 Thousand
Total Non-Current Assets 5.71 Million 5.54 Million 2.65 Million 416 Thousand 2.67 Million -
Net PPE 1.06 Million 1.51 Million 954 Thousand 416 Thousand 442 Thousand -
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments - 54 Thousand 175 Thousand 88 Thousand 88 Thousand -
Tax Assets - - - - - -
Other Non Current Assets 4.65 Million 3.97 Million 1.53 Million -88 Thousand 2.14 Million -
Other Assets - - 0.00 - - -
Total Liabilities 25.96 Million 160.12 Million 156.21 Million 151.3 Million 4.38 Million 1.83 Million
Total Current Liabilities 25.89 Million 9.71 Million 5.75 Million 1.47 Million 4.19 Million 1.83 Million
Account Payables 532 Thousand 3.43 Million 2.52 Million 808 Thousand 1.65 Million 908 Thousand
Tax Payables - - - - - -
Short Term Debt 335 Thousand 323 Thousand 159 Thousand 105 Thousand - -
Deferred Revenue - 5.5 Million 2.7 Million 429 Thousand - -
Other Current Liabilities 25.02 Million 447 Thousand 370 Thousand 136 Thousand 2.54 Million 924 Thousand
Total Non Current Liabilities 67 Thousand 150.4 Million 150.46 Million 149.82 Million 183.99 Thousand 32.18 Million
Long-Term Debt - 277.00 - - - -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 67 Thousand 150.4 Million 150.46 Million 149.82 Million 183.99 Thousand 32.18 Million
Other Liabilities - - - - 1.00 -32.18 Million
Total Equity 245.9 Million -76.82 Million -42.88 Million -20.3 Million -48.84 Million -26.31 Million
Stock Holders Equity 245.9 Million -76.82 Million -42.88 Million -20.3 Million -48.84 Million -26.31 Million
Common Stock 41 Thousand 1000.00 1000.00 1000.00 4000.00 4000.00
Retained Earnings -154.44 Million -82.86 Million -45.2 Million -20.46 Million -54.75 Million -31.29 Million
Accumulated other comprehensive income 141 Thousand -149.74 Thousand -16 Thousand 4000.00 32 Thousand -
Common Stock Equity 245.9 Million -76.82 Million -42.88 Million -20.3 Million -48.84 Million -26.31 Million
Capital Lease Obligation 335 Thousand 323 Thousand 159 Thousand 105 Thousand - -
Total Investments 153 Million 54 Thousand 42.14 Million 40.61 Million 24.05 Million -
Total Debt 335 Thousand 323 Thousand 159 Thousand 105 Thousand - -
Net Debt -99.86 Million -75.21 Million -109.86 Million -130.26 Million -4.93 Million -7.38 Million

Balance Sheet Charts

Created with Highcharts 11.1.0Value in USDYearly Balance Sheet BreakdownCurrent AssetsNon-Current AssetsCurrent LiabilitiesNon-Current LiabilitiesEquity20202021202220230100 M200 M300 M
Created with Highcharts 11.1.0Current RatioWorking CapitalAnnual Working CapitalSource: YRWorking CapitalCurrrent Ratio2020202120222023020406080100060 M120 M180 M240 M300 M